We would love to hear your thoughts about our site and services, please take our survey here.
857m - share price over 10euros for certain - slow moving up
Looks like going over 11euros even over 13euros if all goes to plan
Its a waiting game - the company has a plan so lets wait
This is like a ticking time bomb - POLB 001 - Severe Influenza treatment and CAR T cell companion therapy. POLB 002 -Respiratory virus infections treatment & prophylactic. POLB 003 -Melioidosis vaccine candidate = Grant funding soon. We will more then double from here johnhume !!!!!!!!!!!!!!!!
“Nobody else has this data. Nobody else has this challenge data to analyze. So I think this is where Poolbeg is unique.” - Very good times ahead !
It’s ripe for a partnership deal and the team at Poolbeg has allowed and are continuing to let the industry know about it at big biotech events throughout the year that chief executive Jeremy Skillington calls “partnering conferences” including recent ones in Dublin, Leuven and Boston. There’s no rush though stresses Skillington as “it is our Crown Jewels. Prize assets. So we’re going to be very careful with who we partner with there, but we see multiple paths forward here.”
Poolbeg noted the data set had previously identified drug targets, specifically p38 MAP kinase which Poolbeg’s POLB 001 treatment has proved effective in targeting, but used manual analysis that took several years. Using AI, that was cut to 15 months, and multiple targets were identified. The analysis also backed up the POLB 001 treatment programme by independently confirming the significance of the p38 MAP kinase pathway in influenza.
Got 1k 8.47euros - We will likely stay at this price for a few weeks - BAN SHORTING !
The short is working now - started 9.15 but unlikely to fall much under 8.50euros - when they buy back it will fly over 10euros again - more profits results 31july buy
In december HVO was 10p i was going to buy alot it went up to 25p - same will happen here!
Interesting trades - bit like POLB my other star buy - who will double first 0.80 here POLB 18p i think here but for certain 15p there - Very positive is coming
Fair value 15p at the moment
Sinéad Bleiel, founder and chief scientific officer of AnaBio Technologies, added: “Having demonstrated the potential of our encapsulation technology to deliver drug products safely and effectively to the gut, we are excited to collaborate with the EncOVac team of world class researchers, led by Poolbeg and supported by the Irish Government as part of the world’s renewed fight against infectious diseases.” This got me on the hook at the start - Takeover if all goes well
Short closing
This will more then double very easy - 30p TP
Over 9p soon - probably a update tomorrow before the big news - so certain
The team Jeremy Skillington, PhD, Ian O'Connell & David English look forward to meeting with industry colleagues at the BIO International Convention.
📍 Boston, MA
📅5-8 June 2023
💬#POLB 001, #AI programmes & our exciting pipeline
Around 9.15euros - They are doing a big attack now it will fail so funny
It will probably close out very soon
That explains it now -why we are not over 10euros, with the buyback going on and profits set to rise alot more - that short position will fail, the last short was 2euros remember - very strange thinking this time